UOC
ICVX

UBS O'Connor’s Icosavax, Inc. Common Stock ICVX Stock Holding History

UBS O'Connor’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-79,000
Closed -$556K – 1036
2022
Q1 		$556K Buy
+79,000
New +$1.24M 0.01% 742

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

UBS O'Connor's ICVX Position: Q2 2022 in Review

UBS O'Connor sold out of Icosavax, Inc. Common Stock (ICVX) in Q2 2022, closing a stake of 79,000 shares — an estimated $556K sold.

UBS O'Connor first reported a position in ICVX in Q1 2022 and held it in 1 quarter. The position peaked at $556K in Q1 2022. 57 funds tracked by Wall St. Rank hold ICVX as of Q2 2022.

  • UBS O'Connor reported no remaining Icosavax, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • UBS O'Connor sold 79,000 Icosavax, Inc. Common Stock shares in Q2 2022, an estimated $556K.
  • UBS O'Connor first reported a position in Icosavax, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • UBS O'Connor's Icosavax, Inc. Common Stock position peaked at $556K in Q1 2022.
  • 57 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q2 2022.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.